Related Experiment Video
Updated: Jul 3, 2026
06:21
Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
DOE program--developing a scientific basis for responses to low-dose exposures: impact on dose-response relationships
Antone L Brooks1, Lezlie Couch
1Washington State University Tri-Cities, 2710 University Drive, Richland, WA 99354, USA.
Summary
The DOE Low Dose Radiation Research Program investigates biological responses to low-dose radiation using advanced genomics. This research aims to link cellular mechanisms to human population risks for better radiation safety.
Area of Science:
- Radiation Biology
- Genomics
- Molecular Toxicology
Background:
- The Department of Energy (DOE) Low Dose Radiation Research Program investigates biological responses to low doses (< 0.1Gy) of low and high-linear energy transfer (LET) radiation.
- This program integrates novel technologies with cutting-edge genomics to observe previously undetectable radiation-induced cellular and molecular changes.
Purpose of the Study:
- To elucidate biological mechanisms underlying responses to low-dose radiation.
- To characterize the dose-response relationship for radiation effects at the cellular and molecular levels.
- To bridge the gap between fundamental radiobiology and human population risk assessment for low-level radiation exposure.
Main Methods:
- Utilizing advanced genomics and cutting-edge biological techniques.
- Observing radiation-induced cellular and molecular alterations.
- Analyzing DNA damage and repair, gene expression changes, adaptive responses, and bystander effects.
Main Results:
- Identified new biological phenomena at low radiation doses, including initial DNA damage, repair, gene expression modulation, adaptive responses, and bystander effects.
- Characterized mechanisms of radiation interaction with living systems.
- Provided insights into the role of radiation in the carcinogenic process.
Conclusions:
- Low-dose radiation exposure triggers complex cellular and molecular responses.
- Direct extrapolation of cellular-level data to human population risks requires careful development of dose-response relationships.
- Integrating basic scientific data with epidemiological methods is crucial for improving low-level radiation risk estimation.
More Related Videos
Related Concept Videos
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...